Showing results (31-40 of 214) with videos related to
Sort By:
Pageof 22
Journal of Medicinal Chemistry|February 7, 2008
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationshipsAdriana Chilin, Roberto Battistutta, Andrea Bortolato, et al.Journal of Medicinal Chemistry|April 14, 2006
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening applicationGiorgio Cozza, Paolo Bonvini, Elisa Zorzi, et al.Chembiochem : a European Journal of Chemical Biology|November 30, 2006
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitorsMario A Pagano, Giorgia Poletto, Giovanni Di Maira, et al.Cellular and Molecular Life Sciences : CMLS|February 14, 2020
Prevalence and significance of the commonest phosphorylated motifs in the human proteome: a global analysisLuca Cesaro, Lorenzo A PinnaMolecular Biosystems|August 16, 2008
Protein kinase CK2 as a druggable targetStefania Sarno, Lorenzo A PinnaFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 13, 2003
One-thousand-and-one substrates of protein kinase CK2?Flavio Meggio, Lorenzo A PinnaBiochimica Et Biophysica Acta|August 12, 2009
Addiction to protein kinase CK2: a common denominator of diverse cancer cells?Maria Ruzzene, Lorenzo A PinnaMolecular Biosystems|July 28, 2015
The generation of phosphoserine stretches in phosphoproteins: mechanism and significanceLuca Cesaro, Lorenzo A PinnaBiochemistry|October 6, 2004
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo studyFlavio Meggio, Mario A Pagano, Stefano Moro, et al.Scientific Reports|February 6, 2019
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regressionZeynep Kabakci, Simon Käppeli, Claudio Cantù, et al.Pageof 22